Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Ref Type | |||||||||||||
PMID | |||||||||||||
Authors | David S. Hong, Anna F. Farago, Marcia S. Brose, Howard A. Burris, III, Afshin Dowlati, Todd M. Bauer, Matthew Taylor, Alice T. Shaw, Adriana Estrada-Bernal, Anh T. Lee, Nisha Nanda, Michael C. Cox, Robert C. Doebele | ||||||||||||
Title | Clinical safety and activity from a phase I study of LOXO-101, a selective TRKA/B/C inhibitor, in solid-tumor patients with NTRK gene fusions | ||||||||||||
|
|||||||||||||
URL | http://www.abstractsonline.com/Plan/ViewAbstract.aspx?mID=4017&sKey=dc4584a4-d39b-485a-9579-be210c4876e9&cKey=42a9d641-458f-4de1-a852-2f8a6fd52de3&mKey=1d10d749-4b6a-4ab3-bcd4-f80fb1922267 | ||||||||||||
Abstract Text | AACR Apr 2016, abstract # CT008 |